Rossini Luxembourg

Rossini S.à r.l. is a Luxembourg-based investment holding company controlled by CVC Capital Partners, established primarily to manage a majority ownership stake in the international pharmaceutical group Recordati. Through its subsidiary Recordati, Rossini operates as a major player in the European specialty healthcare and global orphan drug markets. The company's portfolio includes a wide range of treatments for primary care, with a strategic emphasis on rare diseases, endocrinology, and cardiology. Rossini supports the long-term growth and acquisition strategy of its underlying assets, focusing on expanding clinical pipelines and geographic reach, particularly in North America. The entity serves as the central vehicle for private equity investment in high-value pharmaceutical manufacturing and commercialization.